Call for Abstracts

The Scientific Committee invites all attendees to submit abstracts for presentation at the upcoming meeting. Abstracts will be considered for e-poster presentation only (no oral presentations).

Guidelines for Submission

• Abstracts must be submitted electronically through the designated submission portal.
• Submissions should not exceed 300 words, excluding title, authors, and affiliations.
• Abstracts must be written in English.
• Structured format is preferred (Background, Methods, Results, Conclusion).
• Previously published or presented work should be clearly indicated.

Topics

• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma
• CAR T-cell therapy and Bispecific
• Multiple Myeloma
• Systemic Therapies for Lymphomas

Important Information

• Submission Deadline: December 15, 2025 at 12pm EST
• Notification of Acceptance: January 5, 2026
• Accepted abstracts will be displayed as e-posters during the meeting.
• Registration fees will be waived for the presenting author of each accepted abstract.

The Committee strongly encourages submissions from clinicians, researchers, and trainees engaged in the field.